Skip to main content
. 2012 Aug;97(8):1165–1172. doi: 10.3324/haematol.2011.055699

Figure 4.

Figure 4.

Determination of the pharmacokinetic properties of GDXa and FXa in plasma. Normal plasma was spiked with 50 nM FXa (A) or GDXa (B), and incubated at 37°C. Aliquots were removed at different times and immediately diluted 25 times in buffer A for determination of residual activity. Half-lives were 1.4±0.1 min for FXa and 1.8±0.1 min for GDXa. Data are the mean of two different experiments.